The role of antiviral drugs in the treatment of dengue fever has been limited, but is currently widely studied. Focusing on the natural characteristics of dengue, this acute febrile illness can be ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Dengue fever is a disease spread by the vector called Aedes mosquito, which breeds on still water that gets collected especially after the end of the summer. It is primarily transmitted by the ...

Island Pharmaceuticals has completed subject dosing for the phase 2b therapeutic arm of its phase 2a/b PROTECT clinical trial ...

The drug, produced by the laboratory Takeda, targets “dengue virus 2” and protects ... and Medical Technology (Anmat) approved the treatment which is already available at private vaccination ...

In severe cases, dengue can be fatal. Dengue is treated with pain medicine as there is no specific treatment currently. Therefore people should be aware of the risks of dengue fever.  According to the ...

for the treatment of dengue in adults above 18 years old. The SEC, which looked into requests on antimicrobial and antiviral drugs in a meeting held recently, said that after detailed deliberation, it ...

to review the situation of dengue fever nationwide and agreed to review the use of the Japanese-developed Qdenga vaccine next year. The 25 healthcare experts concurred that the drug's efficacy is ...

The ongoing research on antiviral drugs might be the clue to better treatment. Dengue has become a widespread infection over the past few year, extending from endemic to nonendemic areas.

Dengue virus infects up to 400 million people worldwide each year according to World Health Organization estimates, and no available treatments exist for this disease. ... Dengue Fever Infections ...